64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
暂无分享,去创建一个
R Laforest | F Dehdashti | P. Cutler | Jason S. Lewis | R. Laforest | J. Lewis | D. McCarthy | L. Bass | C. Anderson | F. Dehdashti | S. Schwarz | J S Lewis | P D Cutler | D W McCarthy | L A Bass | C J Anderson | S W Schwarz | C. J. Anderson | Jason S. Lewis
[1] P. Cutler,et al. Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] K. Zinn,et al. Production of no‐carrier‐added 64Cu from zinc metal irradiated under boron shielding , 1994, Cancer.
[3] P. Cutler,et al. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] E. Krenning,et al. In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. , 1993, Blood.
[5] T. Visser,et al. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] M G Stabin,et al. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] J. Bertherat,et al. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. , 1995, The Journal of clinical endocrinology and metabolism.
[8] E P Krenning,et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] T. Visser,et al. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. , 1991, Life sciences.
[10] E. Krenning,et al. Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] M. Welch,et al. Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] G. Denardo,et al. Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients. , 1999, Nuclear medicine and biology.
[13] M. Welch,et al. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. , 2000, Bioconjugate chemistry.